Rivaroxaban-Excipient Compatibility Studies For Advanced Drug Delivery Systems Development
Abstract
The main objective of the present study was to the preformulation studies were performed to know the physico-chemical and mechanical properties of Rivaroxaban for formulation development of ODTs. The drug-excipient compatibility studies were conducted to characterize the drug Rivaroxaban present in Orodispersible tablets (ODTs). The safety, efficacy, quality and stability of a formulation are major concepts of any API development process. In API development process, a detailed characterization of the API and other formulation components is usually carried out during the preformulation stage.
Preformulation, formulation and evaluation of Rivaroxaban to avoid problems associated with conventional delivery system such as limited permeation, low dissolution and bioavailability and also to improve bioavailability and oral anticoagulant effect. In the present study that the compatibility was assessed by, FTIR spectroscopy, and melting point apparatus, precompression parameters and powder flow properties. Results showed that physical mixtures of Rivaroxaban and various excipients as mannitol, microcrystalline cellulose as diluents, and sodium starch glycolate, croscarmellose sodium, and crospovidone as superdisintegrants sodium lauryl sulfate as wetting agents were evaluated for preformulation studies parameters.
It was concluded that the drug Rivaroxaban was found to be compatible with various excipients which were selected for the formulation development of the Rivaroxaban ODTs. Formulation scientist from his experience and knowledge have to significantly in the preformulation study stage and is an important factor in the ADDS (Advanced Drug Delivery Systems) product development process.
Download the full article as PDF here Rivaroxaban-Excipient Compatibility Studies For Advanced Drug Delivery Systems Development
or read it here
Materials
Rivaroxaban and Acetonitrile were gift from (Modern Pharmaceutical Industry Company-Yemen). Crospovidone, Sodium Starch Glycolate, Croscarmellose Sodium, Avicel 102, Mannitol, PVP K30, Sodium Lauryl Sulfate, Aerosil, Magnesium Stearate, Talc, Aspartame, Saccharin Sodium, Vanilla Flavor, Distilled Water, Sodium Hydroxide, Monobasic Potassium Phosphate and Potassium Bromide were gift from (Shaphaco Pharmaceutical Industry Company-Yemen).
Mahmoud Mahyoob Alburyhi, Mohammed Abbas Hamidaddin, Maged Alwan Noman, Abdalwali Ahmed Saif, Tawfeek A. A. Yahya and Mokhtar Abd-hafiz Al-Ghorafi, Rivaroxaban-Excipient Compatibility Studies For Advanced Drug Delivery Systems Development, SJIF Impact Factor 7.065, EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, Research Article ISSN 2394-3211, www.ejpmr.com, EJPMR
Read also our introduction article on Magnesium Stearate here:
